Absorption, distribution and excretion of 14C‐levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin‐related radioactivity to melanin in vivo
Identifieur interne : 000214 ( Istex/Curation ); précédent : 000213; suivant : 000215Absorption, distribution and excretion of 14C‐levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin‐related radioactivity to melanin in vivo
Auteurs : Makoto Tanaka [Japon] ; Chiho Ono [Japon] ; Masayoshi Yamada [Japon]Source :
- Journal of Pharmacy and Pharmacology [ 0022-3573 ] ; 2004-04.
English descriptors
- Teeft :
- Albino, Albino rats, Binding characteristics, Binding mechanisms, Chloroquine, Dosing, Electrostatic forces, Excretion, Feces, Fluoroquinolones, Hemihydrate, High affinity, Higher concentrations, Important role, Larsson, Larsson tjalve, Levofloxacin, Levofloxacin hemihydrate, Limited extent, Male rats, Melanin, Melanin binding, Neutral phosphate buffer, Ocular, Ocular pharmacokinetics, Ocular tissues, Ocular toxicity, Pharmacol, Phosphate buffer, Radioactivity, Radioactivity concentrations, Rat, Serum concentrations, Stepien wilczok, Synthetic melanin, Tanaka, Tjalve, Total radioactivity, Toxicity, Unchanged levofloxacin, Urine, Uveal, Uveal tract, Uveal tract extracts, Uveal tract radioactivity concentrations, Uveal tracts, Waals.
Abstract
After single oral administration of 14C‐levofloxacin at a dose of 20 mg kg−1 under non‐fasting conditions, the absorption, distribution and excretion of radioactivity were studied in albino and pigmented rats. Good penetration of radioactivity into tissues was indicated by higher concentrations in most tissues compared with serum and there were no quantitative differences in the distribution of radioactivity between albino and pigmented rats except for melanin‐containing tissues such as the uveal tract of eyes and hair follicles. There was selective and strong binding of drug‐related radioactivity to these tissues in pigmented rats. The uveal tract concentrations reached the maximum value (Cmax) of 26.33 + 0.75 μg eq.g−1 at 24 h after dosing and declined slowly with a terminal half‐life of 468.1 h (19.5 days). The uveal tract concentration at 12 weeks was 0.73 + 0.12 μg eq.g−1, which is c. 1/36 of Cmax. The AUC0‐∞ for the uveal tract was 12.58 mg h−1 g−1. The uveal tracts separated from one eye of each rat were extracted with 0.067 m phosphate buffer (pH 7.4) and 1m HCl/EtOH (30:70), successively. In pigmented rats, approximately 85–48% of radioactivity bound to the uveal tract was released from the tissue by the washing procedures. Most of the eluted radioactivity was released with 1m HCl/EtOH (30:70), indicating that the binding to melanin is reversible, and hydrophobic and electrostatic interactions play an important role in the binding of levofloxacin and/or its metabolites with melanin‐containing ocular tissues. Only unchanged drug was detected in the extracts of the uveal tracts. The concentrations and half‐life of radioactivity in the uveal tract after dosing of 14C‐levofloxacin were found to be much lower and shorter than those after dosing of 14C‐chloroquine. It is unlikely that levofloxacin causes toxicity because of its much lower affinity to melanin‐containing ocular tissues and shorter duration of therapy compared to chloroquine.
Url:
DOI: 10.1211/0022357023141
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000214
Links to Exploration step
ISTEX:736ADC27AC9E09F8B8F9FE86A601C97A5C0DEEDBLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Absorption, distribution and excretion of 14C‐levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin‐related radioactivity to melanin in vivo</title>
<author><name sortKey="Tanaka, Makoto" sort="Tanaka, Makoto" uniqKey="Tanaka M" first="Makoto" last="Tanaka">Makoto Tanaka</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: tanak6m1@daiichipharm.co.jp</mods:affiliation>
<country wicri:rule="url">Japon</country>
</affiliation>
</author>
<author><name sortKey="Ono, Chiho" sort="Ono, Chiho" uniqKey="Ono C" first="Chiho" last="Ono">Chiho Ono</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yamada, Masayoshi" sort="Yamada, Masayoshi" uniqKey="Yamada M" first="Masayoshi" last="Yamada">Masayoshi Yamada</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:736ADC27AC9E09F8B8F9FE86A601C97A5C0DEEDB</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1211/0022357023141</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-WRTCNQ19-3/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000214</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000214</idno>
<idno type="wicri:Area/Istex/Curation">000214</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Absorption, distribution and excretion of 14C‐levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin‐related radioactivity to melanin in vivo</title>
<author><name sortKey="Tanaka, Makoto" sort="Tanaka, Makoto" uniqKey="Tanaka M" first="Makoto" last="Tanaka">Makoto Tanaka</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>E-mail: tanak6m1@daiichipharm.co.jp</mods:affiliation>
<country wicri:rule="url">Japon</country>
</affiliation>
</author>
<author><name sortKey="Ono, Chiho" sort="Ono, Chiho" uniqKey="Ono C" first="Chiho" last="Ono">Chiho Ono</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Yamada, Masayoshi" sort="Yamada, Masayoshi" uniqKey="Yamada M" first="Masayoshi" last="Yamada">Masayoshi Yamada</name>
<affiliation wicri:level="1"><mods:affiliation>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630, Japan</mods:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Drug Metabolism and Physicochemical Property Research Laboratory, Daiichi Pharmaceutical Co. Ltd, 16–13, Kita‐Kasai 1‐Chome, Edogawa‐ku, Tokyo 134–8630</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Pharmacy and Pharmacology</title>
<title level="j" type="alt">JOURNAL OF PHARMACY AND PHARMACOLOGY</title>
<idno type="ISSN">0022-3573</idno>
<idno type="eISSN">2042-7158</idno>
<imprint><biblScope unit="vol">56</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="463">463</biblScope>
<biblScope unit="page" to="469">469</biblScope>
<biblScope unit="page-count">7</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2004-04">2004-04</date>
</imprint>
<idno type="ISSN">0022-3573</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0022-3573</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Albino</term>
<term>Albino rats</term>
<term>Binding characteristics</term>
<term>Binding mechanisms</term>
<term>Chloroquine</term>
<term>Dosing</term>
<term>Electrostatic forces</term>
<term>Excretion</term>
<term>Feces</term>
<term>Fluoroquinolones</term>
<term>Hemihydrate</term>
<term>High affinity</term>
<term>Higher concentrations</term>
<term>Important role</term>
<term>Larsson</term>
<term>Larsson tjalve</term>
<term>Levofloxacin</term>
<term>Levofloxacin hemihydrate</term>
<term>Limited extent</term>
<term>Male rats</term>
<term>Melanin</term>
<term>Melanin binding</term>
<term>Neutral phosphate buffer</term>
<term>Ocular</term>
<term>Ocular pharmacokinetics</term>
<term>Ocular tissues</term>
<term>Ocular toxicity</term>
<term>Pharmacol</term>
<term>Phosphate buffer</term>
<term>Radioactivity</term>
<term>Radioactivity concentrations</term>
<term>Rat</term>
<term>Serum concentrations</term>
<term>Stepien wilczok</term>
<term>Synthetic melanin</term>
<term>Tanaka</term>
<term>Tjalve</term>
<term>Total radioactivity</term>
<term>Toxicity</term>
<term>Unchanged levofloxacin</term>
<term>Urine</term>
<term>Uveal</term>
<term>Uveal tract</term>
<term>Uveal tract extracts</term>
<term>Uveal tract radioactivity concentrations</term>
<term>Uveal tracts</term>
<term>Waals</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">After single oral administration of 14C‐levofloxacin at a dose of 20 mg kg−1 under non‐fasting conditions, the absorption, distribution and excretion of radioactivity were studied in albino and pigmented rats. Good penetration of radioactivity into tissues was indicated by higher concentrations in most tissues compared with serum and there were no quantitative differences in the distribution of radioactivity between albino and pigmented rats except for melanin‐containing tissues such as the uveal tract of eyes and hair follicles. There was selective and strong binding of drug‐related radioactivity to these tissues in pigmented rats. The uveal tract concentrations reached the maximum value (Cmax) of 26.33 + 0.75 μg eq.g−1 at 24 h after dosing and declined slowly with a terminal half‐life of 468.1 h (19.5 days). The uveal tract concentration at 12 weeks was 0.73 + 0.12 μg eq.g−1, which is c. 1/36 of Cmax. The AUC0‐∞ for the uveal tract was 12.58 mg h−1 g−1. The uveal tracts separated from one eye of each rat were extracted with 0.067 m phosphate buffer (pH 7.4) and 1m HCl/EtOH (30:70), successively. In pigmented rats, approximately 85–48% of radioactivity bound to the uveal tract was released from the tissue by the washing procedures. Most of the eluted radioactivity was released with 1m HCl/EtOH (30:70), indicating that the binding to melanin is reversible, and hydrophobic and electrostatic interactions play an important role in the binding of levofloxacin and/or its metabolites with melanin‐containing ocular tissues. Only unchanged drug was detected in the extracts of the uveal tracts. The concentrations and half‐life of radioactivity in the uveal tract after dosing of 14C‐levofloxacin were found to be much lower and shorter than those after dosing of 14C‐chloroquine. It is unlikely that levofloxacin causes toxicity because of its much lower affinity to melanin‐containing ocular tissues and shorter duration of therapy compared to chloroquine.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000214 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000214 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:736ADC27AC9E09F8B8F9FE86A601C97A5C0DEEDB |texte= Absorption, distribution and excretion of 14C‐levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin‐related radioactivity to melanin in vivo }}
This area was generated with Dilib version V0.6.33. |